Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75

Fig. 3

Survival analysis between GIRS subgroups and nomogram development in the TCGA-BLCA training cohort. A Kaplan–Meier curve analysis of OS between high and low GIRS subgroups. B Time-dependent ROC analysis of GIRS for predicting OS at 1, 3, and 5 years. C The distribution of GIRS signature, the vital status of patients, and the expression of GIRGs. D Nomogram development. E Time-dependent ROC curves at 1, 3, and 5 years of the nomogram. F–H The calibration plots of nomogram for predicting BCa patients with 1, 3, and 5-year OS. The nomogram’s ideal performance is shown by the dashed lines. I–K The decision curve analysis of nomogram and other clinical factors for 1, 3, and 5-year risk. The black line represents the hypothesis that no patient died after 1, 3, and 5 years

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us